The combinatorial effects of familial mutations, oxidative stress, and aging on BBB dysfunction in Alzheimer's disease
The combinatorial effects of familial mutations, oxidative stress, and aging on BBB dysfunction in Alzheimer's disease
批准号:
10464625
负责人:
Tracy D. Chung
金额:
$4.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2026-06-30
关键词:
AddressAffectAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease riskAmericanAmyloidAmyloid beta-ProteinAnimalsAutopsyBiologicalBiological AssayBloodBlood - brain barrier anatomyBlood CirculationBlood VesselsCategoriesCellsCerebral Amyloid AngiopathyCerebrovascular systemCommunicationComplexCuesDataData SetDevelopmentDiseaseDisease ProgressionEndothelial CellsEtiologyExposure toFellowshipFunctional disorderFutureGene ExpressionGene set enrichment analysisGoalsHumanHydrogen PeroxideImageImmunohistochemistryImpaired cognitionImpairmentIndividualInduced MutationInstitutesInstitutionInterventionLeadershipLibrariesMemory LossMentorshipMicrofabricationModelingMolecularMutationNerve DegenerationNeurofibrillary TanglesOnset of illnessOutcomeOxidative StressPathologicPathologyPathway interactionsPerfusionPermeabilityPharmacology StudyPhenotypePhysiologicalPreventionProteomicsPublishingResearch TrainingResolutionRoleSenile PlaquesSerumStructural defectSymptomsTherapeuticTissue EngineeringTissuesToxinTrainingTransgenic MiceUniversitiesValidationVascular Diseasesabeta depositionage relatedagedbaseblood-brain barrier disruptionblood-brain barrier functionbrain cellbrain endothelial cellbrain tissuecareercombinatorialdesigndisabilityeducation resourcesepidemiology studyexperimental studyextracellularfamilial Alzheimer diseasegenetic signatureglucose transporthuman old age (65+)imaging studyin vitro Modelin vivonanobiotechnologyoccludinpresenilin-1responseskillssolutespatiotemporalstem cell differentiationstem cellssuccesstranscriptome sequencingtranscriptomics
中文摘要
项目摘要
阿尔茨海默氏症是一种影响数百万美国人的神经退化和衰老疾病,
在没有进一步重大突破的情况下,预计会影响更多的人。1然而,大部分病因
阿尔茨海默氏症的进展仍然不清楚,特别是考虑到许多不同的
与表型结果相关的分子、细胞和环境线索。一个新兴的焦点
在阿尔茨海默病的研究中,脑血管系统在阿尔茨海默病的发生、发展和恶化中所起的作用
症状性疾病2-4血脑屏障的破坏,严密地控制着
体循环和脑组织,已表现在尸检和活体研究的晚期
阿尔茨海默病,表现为微出血、葡萄糖转运功能障碍和毒素外排障碍;额外5例
动物研究表明,一些血管功能障碍先于神经元变性。
6,7因此,为了了解阿尔茨海默病的驱动因素和进展,
希望找到治疗的突破点,必须研究血脑屏障功能障碍的作用。
为此,我们建议使用具有高度时空特性的血脑屏障组织工程模型。
在与阿尔茨海默氏症相关的三种关键扰动类别下评估其功能障碍的决议
疾病。这些干扰将跨越与阿尔茨海默氏症(APP(瑞氏)和阿尔茨海默病(APP)相关的细胞固有突变
PSEN(M146V),氧化应激的外在信号(过氧化氢暴露),以及
老年人血液成分(接触老年人与年轻人的血清)。我们假设这个组合
该方法将最好地概括阿尔茨海默病患者的人类BBB表型,并允许对每种表型进行模块化研究
贡献者。这些干扰将从转录、蛋白质组和功能上进行比较。
将通过批量RNA测序和基因集浓缩分析来研究转录变化
突出与已发表的人类数据集的相似性,识别受阿尔茨海默氏症影响的标志性路径
提示,并激励功能分析设计,以便在组织工程模型中进一步验证。蛋白质组学
功能评估包括屏障功能、细胞身份和通路验证的变化
转录本分析显示。这项研究将提供对血液作用的更深层次的理解-
阿尔茨海默病进展中的脑障碍,并强调未来干预的候选目标。
该项目和相关的研究培训将在约翰斯的Peter Searson博士的指导下进行
霍普金斯大学和纳米生物技术研究所。技能包括功能分析设计、干细胞
分化、显微制造和RNA测序分析将得到教育资源的支持
在机构内可用。研究金培训期的其他目标将包括专业人员
未来事业成功的发展,重点是沟通、指导和领导技能。
英文摘要
Project Abstract
Alzheimer’s disease is a disease of neurodegeneration and aging that affects millions of Americans, and is
expected to impact millions more without further significant breakthroughs.1 However, much of the etiology
and progression of Alzheimer’s is still unclear, especially given the complex interactions of many different
molecular, cellular, and environmental cues that are correlated with phenotypic outcomes. An emerging focus
in Alzheimer’s study is the role of the cerebrovasculature in the initiation, progression, and exacerbation of
symptomatic disease.2-4 Disruption of the blood-brain barrier, which tightly controls any exchange between
systemic circulation and brain tissue, has manifested in post-mortem and in vivo studies of late-stage
Alzheimer’s disease as microbleeds, dysfunctional glucose transport, and impaired efflux of toxins;5 additional
animal studies have indicated that some vascular dysfunction precedes neuronal degeneration in the
progression of the disease.6, 7 Thus, to understand the drivers and progression of Alzheimer’s disease in
hopes of identifying therapeutic breakpoints, the role of blood-brain barrier dysfunction must be investigated.
To do so, we propose using a tissue-engineered model of the blood-brain barrier with high spatiotemporal
resolution to assess its dysfunction under three key categories of perturbation associated with Alzheimer’s
disease. These perturbations will span cell-intrinsic mutations associated with Alzheimer’s (APP(Swe) and
PSEN(M146V)), extrinsic cues of oxidative stress (hydrogen peroxide exposure), and the systemic influence of
aged blood components (exposure to aged vs. young human serum). We hypothesize that this combinatorial
approach will best recapitulate human BBB phenotype in Alzheimer’s, and allow for modular study of each
contributor. These perturbations will be compared transcriptomically, proteomically, and functionally.
Transcriptomic changes will be studied through bulk RNA-sequencing and gene set enrichment analysis to
highlight similarities to published human datasets, identify hallmark pathways that are impacted by Alzheimer’s
cues, and motivate functional assay design for further validation in the tissue-engineered model. Proteomic
and functional assessments include changes to barrier function, cell identity, and validation of pathways
implicated by transcriptomic analysis. This study will provide a deeper understanding of the role of the blood-
brain barrier in Alzheimer’s progression and emphasize candidate targets for future intervention.
This project and related research training will be conducted under the guidance of Dr. Peter Searson at Johns
Hopkins University and the Institute for Nanobiotechnology. Skills including functional assay design, stem cell
differentiation, microfabrication, and RNA-sequencing analysis will be supported by the educational resources
available within the institution. Additional goals of the fellowship training period will incorporate professional
development for future career success, with an emphasis on communication, mentorship, and leadership skills.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The combinatorial effects of familial mutations, oxidative stress, and aging on BBB dysfunction in Alzheimer's disease
-
批准号:10640090
-
项目类别:
-
资助金额:$4.77万
-
财政年份:2022
-
负责人:Tracy D. Chung
-
依托单位:
海外基金